A discrepancy between optimization and planning forward dose calculation between adaptive optimizations and AQA dose calculations can occur.
Source facts
Action
An undated letter was issued via email to customers on 3/18/2019, except for one customer who was issued the letter on 3/26/2019.
Initiated
2019-03-18
Root cause
Software design
Terminated
2022-06-16
Distribution
Distribution was made to FL, IL, MI, MO, NY, and WI. There was no government/military distribution. Foreign distribution was made to Denmark, France, Germany, Netherlands, South Korea, Switzerland, Turkey, UAE,
Recall number
Z-1251-2019
Recall status
Terminated
CDRH record ID
172035
FDA record created
2019-05-02
Recall event number
82612
Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.
Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.